Why the study?
Current rhythm control therapies for AF have high recurrence rates and lack life-prolongation value, potentially because they do not address fundamental mechanisms such as inflammation.
Design
Review
Answers are grounded in this paper and cite their sources.
Inflammation plays a fundamental role in the initiation and maintenance of atrial fibrillation, suggesting that targeting inflammatory pathways may offer new therapeutic approaches beyond traditional rhythm control.
Atrial fibrillation (AF) is one of the most common types of arrhythmias and increases cardiovascular morbidity and mortality. Current therapeutic approaches to AF that focus on rhythm control have high recurrence rates and no life prolongation value. While possible explanations include toxicity of current therapies, another likely explanation may be that current therapies do not address fundamental mechanisms of AF initiation and maintenance. Inflammation has been shown to affect signaling pathways that lead to the development of AF. This paper reviews the roles of inflammation in the occurrence, development, and mechanisms of AF and reviews the therapeutic implications of the correlation of inflammation and AF.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: